Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 34012177 | HLA-CLASS I (HLA CLASS II) | cervical intraepithelial neoplasia | NA | NA | NA | unclassified | |
| altered immunohistochemical expression patterns of hla class i during the clinical course of cervical intraepithelial neoplasia. | |||||||
| 34012177 | HLA-CLASS I (HLA CLASS II) | cervical intraepithelial neoplasia | NA | NA | NA | unclassified | |
| it is unclear how immunohistochemical expression patterns of hla class i in the pre-malignant phase of cervical intraepithelial neoplasia (cin) alter during the clinical follow-up period. | |||||||
| 7827205 | HLA IDENTICAL (HLA-IDENTICAL) | prednisone | NA | methotrexate | NA | unclassified | |
| NA | |||||||
| 16423886 | DQ2 (HAPLOTYPE) | disease her | Caucasian | NA | NA | unclassified | |
| the known human leucocyte antigen (hla)-dq2 and -dq8 association explains only a minority of disease heritability. | |||||||
| 16423886 | DQ8 (HAPLOTYPE) | disease her | Caucasian | NA | NA | unclassified | |
| the known human leucocyte antigen (hla)-dq2 and -dq8 association explains only a minority of disease heritability. | |||||||
| 25635822 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | disease her | European | NA | NA | unclassified | |
| the human leukocyte antigen (hla) region, and 40 newer regions identified by genome wide association studies (gwas) and dense fine mapping, account for ~40% of the disease heritability. | |||||||
| 25903667 | MHC (MHC) | disease her | NA | NA | NA | unclassified | |
| shared genetic predisposition, as shown by familial aggregation, is largely attributable to the major histocompatibility complex (mhc) locus, which was estimated to account for approximately half of the whole disease heritability. | |||||||
| 11000994 | HLA COMPATIBLE (HLA-COMPATIBLE) | autografting | NA | hydroxyurea | NA | unclassified | |
| for patients without hla-compatible donors, current therapeutic options include conventional chemotherapy (hydroxyurea), interferon-alpha (ifn-alpha) and autografting. | |||||||
| 10522900 | HLA-DQA1*01 | reflex sympathetic dystrophy | NA | NA | NA | unclassified | |
| hla-dq1 associated with reflex sympathetic dystrophy. | |||||||
| 21149657 | HLA-A*02 | malignant gliomas | NA | NA | NA | unclassified | |
| purposea phase i/ii trial was performed to evaluate the safety and immunogenicity of a novel vaccination with a-type 1 polarized dendritic cells (adc1) loaded with synthetic peptides for glioma-associated antigen (gaa) epitopes and administration of polyinosinic-polycytidylic acid [poly(i:c)] stabilized by lysine and carboxymethylcellulose (poly-iclc) in hla-a2(+) patients with recurrent malignant gliomas. | |||||||
Copyright 2024